High performance cellular reagents designed with your research goals in mind.

Drug discovery relies on cell-based assay systems to understand target function and how modulation affects cellular processes. High quality stable monoclonal cell lines deliver consistent expression and assay reproducibility, supporting robust high throughput screening and downstream medicinal chemistry cascades with confidence in the data.

Using the latest technologies and thoughtful design, our scientists evaluate hundreds of individual clones at each stage and progress only the best performers. This end-to-end approach delivers rapid and cost-effective stable cell lines and assay systems, reducing workload for your team while keeping you involved in key decisions.

Scientist handling stacked trays in a controlled laboratory environment, representing cell line generation.

Target Classes & Advanced Systems

Our team generates and validates recombinant cell lines across many demanding target families, including ion channels, GPCRs, transporters and cytosolic proteins. We also build advanced cellular tools such as reporter systems, protein-protein interaction models, internalization/trafficking platforms, and real-time signaling biosensors to meet modern discovery needs.

Why Choose Sygnature Discovery for Cell Line
Generation Support?

For more than two decades, we have generated high-quality recombinant cell lines across challenging targets, analyzing hundreds of clones per project to deliver the strongest reagents. We bring deep knowledge of expression systems, host cell types, and troubleshooting strategies that de-risk complex programs. We collaborate with your team, while allowing you to focus on the rest of the discovery research.


Loading…
Lesley Gerrard, PhD
Lesley Gerrard, PhD

Lesley has over 25 years’ experience in cell signaling and cellular pharmacology and has…

Claire Brown
Claire Brown

With over 25 years at Sygnature Discovery, Claire is an experienced molecular biologist specializing…

Lisa McArthur, PhD
Lisa McArthur, PhD

Lisa McArthur is an Associate Principal Scientist in the Cellular Pharmacology department at Sygnature…

Grace Chan
Grace Chan

Grace is a scientist at Sygnature Discovery with over nine years of experience in…

Delivering Custom Cell-Based Tools for Drug Discovery

Ebook

Drug Discovery research heavily relies on cell-based assay systems to investigate cellular functions and processes, and to help understand the effect of modulating specific molecular targets. Challenges associated with the use of primary cultures, such as availability, scalability, and cost, make recombinant cellular systems indispensable for drug discovery. High quality recombinant cell lines provide robust, reliable data and support large-scale high throughput screening, as well as enabling downstream medicinal…
Loading…
High-Throughput Screening Platform and Orthogonal Assays for Apelin Receptor Discovery
High-Throughput Screening Platform and Orthogonal Assays for Apelin Receptor Discovery
The apelin receptor (APLNR) is an emerging therapeutic target with potential application across cardiovascular,…
Posters
Signaling diversity and subtype selectivity of serotonergic psychedelics
Signaling diversity and subtype selectivity of serotonergic psychedelics
As interest in psychedelic therapeutics continues to grow, understanding how these compounds interact with…
Posters
Development of a Multimodal Assay System for GDF15/GFRAL Drug Discovery
Development of a Multimodal Assay System for GDF15/GFRAL Drug Discovery
Transforming Receptor Biology into a Screening-Ready Discovery Platform Successful drug discovery begins with a…
Case Studies

Related Solutions

High Throughput Screening

Integrated hit identification using HTS, fragment screening, and advanced automation delivering high-quality starting points for successful drug discovery.

Ion channels
GPCRs
Transporters
Cell-Based Assays
Biochemical Assays
Biophysical Assays
Primary Cells and Tissues